← Back to Search
Pharmacological Enhancing Agents Targeting Cognition In Patients With Alcohol-induced Neurocognitive Disorders: A Systematic Review
Nicolaj Mistarz, K. Andersen, A. Nielsen, A. Goudriaan, T. Michel, Lotte Skøt, Dorthe Grüner Nielsen, A. Mellentin
Published 2021 · Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Debilitating neurocognitive deficits are seen in alcohol use disorders (AUD) and Wernicke-Korsakoff's syndrome (WKS). These shared characteristics suggest a spectrum of alcohol-induced neurocognitive disorders (AIND). Cognitive pharmacological enhancing agents (CPEA) have been examined in the treatment of other psychiatric disorders, but little is known about the effects of these agents on AINDs. Our aim was to synthesize the evidence for the effectiveness of CPEAs on AINDs. Databases were searched for controlled trials examining CPEAs on AUD, WKS, and alcohol-related dementia (ARD). Eligible studies were included in a qualitative synthesis and a quality assessment was conducted. The search identified 23 studies (4 ≤ ns ≤ 98). Evidence suggests that modafinil may improve executive functions in AUD and ARD, but this effect may only be present in patients with severe deficits. The studies were rated as having a moderate risk of bias. Despite the promising effects of modafinil, small samples and inconsistent evidence deem the results preliminary. More research is warranted examining the effects of transdiagnostic CPEAs on deficits across AINDs.
This paper references
A Standardized Memory Scale for Clinical Use
D. Wechsler (1945)
Short-term retention of individual verbal items.
L. R. Peterson (1959)
An inventory for measuring depression.
A. Beck (1961)
The Wernicke-Korsakoff syndrome. A clinical and pathological study of 245 patients, 82 with post-mortem examinations.
M. Victor (1971)
The Wernicke-Korsakoff Syndrome: A Clinical and Pathological Study of 245 Patients, 82 With Post-Mortem Examinations
D. W. Goodwin (1972)
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.
M. Folstein (1975)
Memory enhancement in Korsakoff's psychosis by clonidine: Further evidence for a noradrenergic deficit
W. Mcentee (1980)
Korsakoff's psychosis: Noradrenergic systems and cognitive impairment
R. Mair (1983)
Lack of effect of desglycinamide-arginine-vasopressin (DGAVP) on memory in patients with korsakoff's syndrome.
F. Laczi (1983)
Noradrenergic and cholinergic agents in Korsakoff's syndrome
O'Donnell Vm (1986)
Treatment of alcoholic organic brain syndrome with the serotonin reuptake inhibitor fluvoxamine: a preliminary study.
J. Stapleton (1988)
Effective pharmacotherapy of alcoholic amnestic disorder with fluvoxamine. Preliminary findings.
P. Martin (1989)
On the treatment of the alcoholic organic brain syndrome with an alpha-adrenergic agonist modafinil: double-blind, placebo-controlled clinical, psychometric and neurophysiological studies
B. Saletu (1990)
Studies of interference in serial verbal reactions.
J. Stroop (1992)
World Health Organization (1992)
Treatment of the alcoholic organic brain syndrome: double-blind, placebo-controlled clinical, psychometric and electroencephalographic mapping studies with modafinil.
B. Saletu (1993)
Korsakoff's syndrome, cognition and clonidine.
R. O'Carroll (1993)
Fluvoxamine treatment of alcoholic amnestic disorder
Peter R. Martin (1995)
Structured clinical interview for DSM-IV axis I disorders : SCID-I: clinical version : administration booklet
M. First (1996)
C. Zubaran (1997)
Context-processing deficits in schizophrenia: converging evidence from three theoretically motivated cognitive tasks.
J. Cohen (1999)
Methylphenidate Abuse and Psychiatric Side Effects.
Morton Wa (2000)
Anticholinesterase drugs for alcoholic Korsakoff syndrome
I. Angunawela (2001)
A case of Korsakoff's syndrome improved by high doses of donepezil.
J. Iga (2001)
A theory of cognitive control, aging cognition, and neuromodulation
T. Braver (2002)
Alcoholism and the Brain: An Overview
M. Oscar-Berman (2003)
A placebo-controlled study of memantine (Ebixa) in dementia of Wernicke-Korsakoff syndrome.
A. Rustembegović (2003)
Rivastigmine in the treatment of alcohol-induced persisting dementia.
R. Gibson (2003)
Influence of Reboxetine on Salivary MHPG Concentration and Cognitive Symptoms Among Patients with Alcohol-Related Korsakoff's Syndrome
T. Reuster (2003)
Cognitive enhancement in Korsakoff's psychosis by clonidine: A comparison with l-Dopa and Ephedrine
R. Mair (2004)
Hippocampal volume and depression: a meta-analysis of MRI studies.
P. Videbech (2004)
Donepezil for Alcohol‐Related Dementia: A Case Report
Kye Y. Kim (2004)
Catecholamine metabolism during clonidine withdrawal
Peter R. Martin (2004)
Effects of fluvoxamine treatment on cognitive functioning in the alcoholic Korsakoff syndrome
R. O'Carroll (2005)
Recent advances in the psychotherapy of addictive disorders
K. Carroll (2005)
Acetylcholinesterase inhibitors for the treatment of Wernicke-Korsakoff syndrome--three further cases show response to donepezil.
M. Cochrane (2005)
Time and decision making: differential contribution of the posterior insular cortex and the striatum during a delay discounting task
M. Wittmann (2006)
Thiamine deficiency decreases glutamate uptake in the prefrontal cortex and impairs spatial memory performance in a water maze test
Fabiana M. Carvalho (2006)
Understanding the health impact of alcohol dependence.
T. Cargiulo (2007)
Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory
S. Vijayraghavan (2007)
Dopamine in drug abuse and addiction: results of imaging studies and treatment implications.
N. Volkow (2007)
Alcohol: Effects on Neurobehavioral Functions and the Brain
M. Oscar-Berman (2007)
Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
D. Hasin (2007)
Cognitive performance in long-term abstinent elderly alcoholics.
G. Fein (2007)
Chapter 38 – Neuropsychiatric Complications of Substance Abuse
G. Ricaurte (2008)
Consequences of alcohol consumption on neurotransmitters -an overview.
Sukhes Mukherjee (2008)
Rivastigmine in Wernicke-Korsakoff's syndrome: five patients with rivastigmine showed no more improvement than five patients without rivastigmine.
Han J Luykx (2008)
Modafinil: A Review of Neurochemical Actions and Effects on Cognition
M. Minzenberg (2008)
The effect of 12-week open-label memantine treatment on cognitive function improvement in patients with alcohol-related dementia.
Y. Cheon (2008)
Dopaminergic and Noradrenergic Contributions to Functionality in ADHD: The Role of Methylphenidate
V. Engert (2008)
The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks
D. Eagle (2008)
Interaction between BDNF and Serotonin: Role in Mood Disorders
K. Martinowich (2008)
The dopamine agonist apomorphine differentially affects cognitive performance in alcohol dependent patients and healthy controls
A. Schellekens (2009)
Dopamine vs Noradrenaline: Inverted-U Effects and ADHD Theories
F. Lévy (2009)
Changes in the episodic memory and executive functions of abstinent and relapsed alcoholics over a 6-month period.
A. Pitel (2009)
Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives.
E. Bora (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
D. Moher (2009)
Brain-derived neurotrophic factor: role in depression and suicide
Yogesh K. Dwivedi (2009)
The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors
G. Danaei (2009)
The neurobehavioral correlates of alcoholism.
Sean B. Rourke (2009)
18. The neurobehavioral correlates of alcoholism
Neurobiology of the adolescent brain and behavior: implications for substance use disorders.
B. Casey (2010)
Research domain criteria (RDoC): toward a new classification framework for research on mental disorders.
T. Insel (2010)
Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.
S. Chatterjee (2010)
The Risks Associated With Alcohol Use and Alcoholism
J. Rehm (2011)
Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control
R. Cools (2011)
Role of the serotonergic system in alcohol dependence: from animal models to clinics.
Y. Sari (2011)
Drug targets for cognitive enhancement in neuropsychiatric disorders
T. Wallace (2011)
Stereological Approaches to Identifying Neuropathology in Psychosis
K. Dorph-Petersen (2011)
Alcohol and the human brain: a systematic review of different neuroimaging methods.
M. Bühler (2011)
National Institute for Health and Care Excellence (2011)
Function and Dysfunction of Prefrontal Brain Circuitry in Alcoholic Korsakoff’s Syndrome
M. Oscar-Berman (2012)
The Effectiveness of Psychosocial Modalities in the Treatment of Alcohol Problems in Adults: A Review of the Evidence
G. Martin (2012)
Cholinergic receptor system as a target for treating alcohol abuse and dependence.
S. Rahman (2012)
Hippocampal Volume Reduction in First-Episode and Chronic Schizophrenia
Fulvia Adriano (2012)
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
H. Whiteford (2013)
Alcohol-related dementia: an update of the evidence
N. Ridley (2013)
BDNF and Schizophrenia: From Neurodevelopment to Neuronal Plasticity, Learning, and Memory
R. Nieto (2013)
Effects of Modafinil on Neural Correlates of Response Inhibition in Alcohol-Dependent Patients
L. Schmaal (2013)
Proof of Concept Trial of Dronabinol in Obstructive Sleep Apnea
B. Prasad (2013)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
R. Lozano (2013)
Levodopa in the treatment of Parkinson's disease: current status and new developments.
D. Salat (2013)
Modafinil Modulates Resting-State Functional Network Connectivity and Cognitive Control in Alcohol-Dependent Patients
L. Schmaal (2013)
Widespread and sustained cognitive deficits in alcoholism: a meta‐analysis
K. Stavro (2013)
A Role for Cognitive Rehabilitation in Increasing the Effectiveness of Treatment for Alcohol Use Disorders
M. Bates (2013)
Effect of modafinil on cognitive functions in alcohol dependent patients: A randomized, placebo-controlled trial
L. Joos (2013)
Neuropsychological rehabilitation in alcohol-related brain damage: a systematic review.
Jenny Svanberg (2013)
Effect of modafinil on impulsivity and relapse in alcohol dependent patients: A randomized, placebo-controlled trial
L. Joos (2013)
American Psychiatric Association (2013)
Neurotransmitters in alcoholism: A review of neurobiological and genetic studies
Niladri Banerjee (2014)
Gray matter and intrinsic network changes in the posterior cingulate cortex after selective serotonin reuptake inhibitor intake
C. Kraus (2014)
The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology
B. Cuthbert (2014)
Neural substrates of impulsive decision making modulated by modafinil in alcohol-dependent patients
L. Schmaal (2014)
Citicoline in addictive disorders: a review of the literature
N. Wignall (2014)
Neuronal nicotinic acetylcholine receptors are important targets for alcohol reward and dependence
Jie Wu (2014)
Nalmefene: a new approach to the treatment of alcohol dependence
F. Paille (2014)
Improvement of a Woman’s Alcohol-Related Dementia via Off-label Memantine Treatment
U. Bonnet (2014)
Interventions for alcohol-related brain damage (ARBD): Do specific approaches restrict the evolution of comprehensive patient care?
L. Horton (2014)
Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals
Joseph P. Schacht (2014)
Pharmacological and non-pharmacological interventions to improve cognitive dysfunction and functional ability in clinical depression – A systematic review
B. Baune (2014)
Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
G. Arbanas (2015)
Corticostriatal BDNF and alcohol addiction
M. Logrip (2015)
Targeting glutamate uptake to treat alcohol use disorders
P. Rao (2015)
Heterogeneity of alcohol use disorder: understanding mechanisms to advance personalized treatment.
R. Litten (2015)
Cognitive enhancing agents in schizophrenia and bipolar disorder
A. Vreeker (2015)
Pharmacotherapy for Alcohol Use Disorder: Current and Emerging Therapies
R. Swift (2015)
Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response—a prospective open-label study
N. Hashimoto (2015)
D-cycloserine to enhance extinction of cue-elicited craving for alcohol: a translational approach
J. MacKillop (2015)
The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
J. Rosenblat (2015)
Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses
B. Bortolato (2015)
The relationship between brain-derived neurotrophic factor and cognitive functions in alcohol-dependent patients: a preliminary study
Changwoo Han (2015)
Alcohol-induced alterations in dopamine modulation of prefrontal activity.
H. Trantham-Davidson (2015)
Visual-induced expectations modulate auditory cortical responses
Virginie van Wassenhove (2015)
Moving the Alcohol Addiction RDoC forward.
K. Sher (2015)
Alcohol-related cognitive impairment: current trends and future perspectives.
Victoria Hayes (2016)
BDNF – a key transducer of antidepressant effects
C. Björkholm (2016)
The serotonergic system and cognitive function
D. Svob Strac (2016)
Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression
M. Udina (2016)
Cognitive Function as a Transdiagnostic Treatment Target in Stimulant Use Disorders
M. Sofuoglu (2016)
Cognitive enhancement treatments for bipolar disorder: A systematic review and methodological recommendations
K. Miskowiak (2016)
Cancer and fertility preservation: international recommendations from an expert meeting
M. Lambertini (2016)
A Critical Role of Brain-Derived Neurotrophic Factor in Alcohol Consumption
S. Pandey (2016)
Cognitive remission: a novel objective for the treatment of major depression?
B. Bortolato (2016)
Problematic alcohol use and reduced hippocampal volume: a meta-analytic review
S. Wilson (2017)
Alcohol consumption and dementia risk: a dose–response meta-analysis of prospective studies
W. Xu (2017)
Korsakoff’s syndrome: a critical review
N. Arts (2017)
Nalmefene Reduces Reward Anticipation in Alcohol Dependence: An Experimental Functional Magnetic Resonance Imaging Study
D. Quelch (2017)
The combined association of alcohol consumption with dementia risk is likely biased due to lacking account of death cases
N. Binder (2017)
Executive Functions, Memory, and Social Cognitive Deficits and Recovery in Chronic Alcoholism: A Critical Review to Inform Future Research
A. Le Berre (2017)
Erythropoietin for Cognitive Deficits Associated with Schizophrenia, Bipolar Disorder, and Major Depression: A Systematic Review.
Xian-Bin Li (2018)
Correlations among Psychological Resilience, Self-Efficacy, and Negative Emotion in Acute Myocardial Infarction Patients after Percutaneous Coronary Intervention
N. Liu (2018)
Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
W. Hsu (2018)
Global statistics on alcohol, tobacco and illicit drug use: 2017 status report
A. Peacock (2018)
Cognitive impairment in substance use disorders
Tatiana Ramey (2018)
Beyond Thiamine: Treatment for Cognitive Impairment in Korsakoff's Syndrome.
Justin M Johnson (2018)
The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
Louisa Fiona Alize Damian Holly Ana Harvey Janni Mohsen M Degenhardt Charlson Ferrari Santomauro Erskine Man (2018)
Alcohol‐induced cognitive deficits are associated with decreased circulating levels of the neurotrophin BDNF in humans and rats
Daniel Silva-Peña (2018)
A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples
Catherine E. Prado (2018)
Effects of Varenicline on Cognitive Performance in Heavy Drinkers: Dose-Response Effects and Associations With Drinking Outcomes
Walter Roberts (2018)
Cognitive dysfunction in major depressive disorder
M. J. Knight (2018)
Can baclofen change alcohol-related cognitive biases and what is the role of anxiety herein?
E. Beraha (2018)
White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder?
E. Schepers (2019)
Immediate impact of minimum unit pricing on alcohol purchases in Scotland: controlled interrupted time series analysis for 2015-18
A. O’Donnell (2019)
Effects of the monoamine stabilizer (-)OSU6162 on cognitive function in alcohol dependence
L. Khemiri (2019)
Widespread Cognitive Deficits in Alcoholism Persistent Following Prolonged Abstinence: An Updated Meta-analysis of Studies That Used Standardised Neuropsychological Assessment Tools.
S. Crowe (2019)
Effect of N-methyl-D-aspartate-receptor-enhancing agents on cognition in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials
Chun-Hung Chang (2019)
Mild Effect of Nalmefene on Alcoholic Cue-Induced Response Invigoration in Alcohol Use Disorder Without Accompanying Changes in Electrophysiological Signatures of Early Visual Processing and Executive Control
B. Gál (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
J. Sterne (2019)
The effects of nalmefene on emotion processing in alcohol use disorder – A randomized, controlled fMRI study
S. Vollstädt-Klein (2019)
Psychiatric comorbidities in alcohol use disorder.
Alvaro Castillo-Carniglia (2019)
Adjunctive memantine for major mental disorders: A systematic review and meta-analysis of randomized double-blind controlled trials
W. Zheng (2019)
A Randomized, Double‐Blind, Placebo‐Controlled Trial of Citicoline in Patients with Alcohol Use Disorder
E. Brown (2019)
Systematic review and exploratory meta-analysis of the efficacy, safety, and biological effects of psychostimulants and atomoxetine in patients with schizophrenia or schizoaffective disorder
M. Solmi (2019)
Impact of Substance Use Disorder Pharmacotherapy on Executive Function: A Narrative Review
K. Butler (2019)
Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs
Marianna A Zolotovskaia (2019)
Brain structural effects of treatments for depression and biomarkers of response: a systematic review of neuroimaging studies
V. Enneking (2019)
Cognitive paths from trauma to posttraumatic stress disorder: a prospective study of Ehlers and Clark's model in survivors of assaults or road traffic collisions
Esther T. Beierl (2019)
Baclofen attenuates fMRI alcohol cue reactivity in treatment-seeking alcohol dependent individuals
W. Logge (2019)
22. Vasopressors and inotropes
Veritas Health Innovation (2019)
Effect of Vortioxetine in Subjects with Major Depressive and Alcohol Use Disorders: A Six-Months Retrospective Analysis.
M. Di Nicola (2020)
A systematic review of treatments for alcohol-related cognitive impairment: lessons from the past and gaps for future interventions
E. Caballeria (2020)
Long-term effects of alcohol consumption on cognitive function: a systematic review and dose-response analysis of evidence published between 2007 and 2018
Sue E Brennan (2020)
Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease
G. Marucci (2021)